187 related articles for article (PubMed ID: 26969740)
1. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
Akiba J; Nakashima O; Hattori S; Naito Y; Kusano H; Kondo R; Nakayama M; Tanikawa K; Todoroki K; Umeno Y; Nakamura K; Sanada S; Yamaguchi R; Ogasawara S; Yano H
J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
[TBL] [Abstract][Full Text] [Related]
2. Keratin 8/18 regulation of glucose metabolism in normal versus cancerous hepatic cells through differential modulation of hexokinase status and insulin signaling.
Mathew J; Loranger A; Gilbert S; Faure R; Marceau N
Exp Cell Res; 2013 Feb; 319(4):474-86. PubMed ID: 23164509
[TBL] [Abstract][Full Text] [Related]
3. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity.
Zhong B; Strnad P; Selmi C; Invernizzi P; Tao GZ; Caleffi A; Chen M; Bianchi I; Podda M; Pietrangelo A; Gershwin ME; Omary MB
Hepatology; 2009 Aug; 50(2):546-54. PubMed ID: 19585610
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
5. Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem-cell features, intermediate-cell type.
Mihara Y; Akiba J; Ogasawara S; Kondo R; Fukushima H; Itadani H; Obara H; Kakuma T; Kusano H; Naito Y; Okuda K; Nakashima O; Yano H
Hepatol Res; 2019 Sep; 49(9):1066-1075. PubMed ID: 31077496
[TBL] [Abstract][Full Text] [Related]
6. Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury.
Toivola DM; Nakamichi I; Strnad P; Michie SA; Ghori N; Harada M; Zeh K; Oshima RG; Baribault H; Omary MB
Am J Pathol; 2008 Apr; 172(4):882-92. PubMed ID: 18349119
[TBL] [Abstract][Full Text] [Related]
7. Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma.
Lim Y; Ku NO
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203895
[TBL] [Abstract][Full Text] [Related]
8. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
[TBL] [Abstract][Full Text] [Related]
9. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.
Ku NO; Strnad P; Bantel H; Omary MB
Hepatology; 2016 Sep; 64(3):966-76. PubMed ID: 26853542
[TBL] [Abstract][Full Text] [Related]
10. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury.
Tao GZ; Toivola DM; Zhong B; Michie SA; Resurreccion EZ; Tamai Y; Taketo MM; Omary MB
J Cell Sci; 2003 Nov; 116(Pt 22):4629-38. PubMed ID: 14576356
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
[TBL] [Abstract][Full Text] [Related]
12. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.
Ku NO; Strnad P; Zhong BH; Tao GZ; Omary MB
Hepatology; 2007 Nov; 46(5):1639-49. PubMed ID: 17969036
[TBL] [Abstract][Full Text] [Related]
13. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
Snider NT; Weerasinghe SV; Iñiguez-Lluhí JA; Herrmann H; Omary MB
J Biol Chem; 2011 Jan; 286(3):2273-84. PubMed ID: 21062750
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review.
Lamps LW; Folpe AL
Adv Anat Pathol; 2003 Jan; 10(1):39-43. PubMed ID: 12502967
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
16. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
Zhao CL; Hui Y; Wang LJ; Yang D; Yakirevich E; Mangray S; Huang CK; Lu S
Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
[TBL] [Abstract][Full Text] [Related]
17. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
Miettinen M; Fetsch JF
Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
[TBL] [Abstract][Full Text] [Related]
18. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
Kim GJ; Kim H; Park YN
PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
[TBL] [Abstract][Full Text] [Related]
20. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
